pfizer back in town - tacere last paper, page-10

Sounds about right Hoyland... I suspect this research work was done before we took Tacere over. If it was done last year then it looks like Pfizer are still very much interested and are the ones likely to lead us to market. It would start with them financing the next phase of trials. They won't move until some clear results are out but the writing is on the wall for a deal in one year.